Related Experiment Video
Updated: Mar 23, 2026
14:54
A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
Published on: January 27, 2019
11.9K
What's New in Paediatric Sepsis
Deborah Farrell1, Simon Nadel1
1St Mary's Hospital and Imperial College London, Praed St, London, W2 1NY UK.
Current Pediatrics Reports
|March 26, 2016
Summary
Severe sepsis and septic shock are major causes of child mortality. Early management is critical, and this review covers recent pediatric sepsis developments over the last three years.
Area of Science:
- Pediatric critical care medicine
- Infectious diseases in children
Background:
- Severe sepsis and septic shock significantly contribute to pediatric mortality and morbidity.
- Optimal treatment strategies for pediatric sepsis are still under investigation, highlighting the need for updated clinical guidance.
Approach:
- This article presents a personal and informal review of recent advancements in pediatric sepsis management.
- Focuses on developments within the last three years to provide current insights.
Key Points:
- Early recognition and intervention are paramount in improving outcomes for children with sepsis.
- Recent research has shed light on evolving treatment pathways, although uncertainties remain.
- The review synthesizes current knowledge on pediatric sepsis for clinicians.
Conclusions:
- Effective initial management is crucial for reducing mortality and morbidity in pediatric severe sepsis and septic shock.
- Continuous review of recent developments is essential for optimizing pediatric sepsis care.
- This review aims to inform and guide healthcare professionals managing pediatric sepsis cases.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
369
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
369
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
322
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
322
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
618
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
618
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
443
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
443
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
678
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
678
01:30Pneumonia III: Complications and Assessment
1.2K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K